Tralokinumab
Product Specifications
CAS Number
1044515-88-9
Target
Interleukin|||Cadherin|||Caspase|||Apoptosis|||IL Receptor
Related Pathways
Cytoskeletal Signaling|||Apoptosis|||Immunology/Inflammation|||Proteases/Proteasome
Purity
1
Bioactivity
Tralokinumab is a fully human IgG4 monoclonal antibody with a high affinity for IL-13 alone. Tralokinumab's potential anti-inflammatory activity prevents IL-13 receptor interaction and subsequent downstream signaling and can be used to study atopic dermatitis (AD) .
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS7271204-01 48 Well
Porcine Eukaryotic peptide chain release factor GTP-binding subunit ERF3A, GSPT1 ELISA Kit
Ask
View Details MBS7271204-02 96 Well
Porcine Eukaryotic peptide chain release factor GTP-binding subunit ERF3A, GSPT1 ELISA Kit
Ask
View Details